Compare Stocks: MRMD, CNXU, GRUSF, and KEQU

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$4.46 +4.9%	$8.09	$4.19 ▼ $18.79	$119.34M	N/A	278,844 shs	114,128 shs
GRUSF Eagleford Energy	$0.44 +0.9%	$0.44	$0.27 ▼ $0.52	N/A	N/A	N/A	21,389 shs
KEQU Kewaunee Scientific	$36.02 +4.3%	$36.67	$32.00 ▼ $46.70	$98.82M	0.73	2,677 shs	1,447 shs
MRMD MariMed	$0.08 -1.1%	$0.07	$0.06 ▼ $0.18	$31.75M	1.35	637,428 shs	412,370 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	0.00%	-10.26%	-44.04%	-60.50%	+445,999,900.00%
GRUSF Eagleford Energy	0.00%	-3.51%	-6.40%	-1.87%	-10.61%
KEQU Kewaunee Scientific	0.00%	-2.61%	-1.44%	-1.92%	-34.13%
MRMD MariMed	0.00%	-1.50%	+21.23%	+14.20%	-45.66%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$4.46 +4.9%	$8.09	$4.19 ▼ $18.79	$119.34M	N/A	278,844 shs	114,128 shs
GRUSF Eagleford Energy	$0.44 +0.9%	$0.44	$0.27 ▼ $0.52	N/A	N/A	N/A	21,389 shs
KEQU Kewaunee Scientific	$36.02 +4.3%	$36.67	$32.00 ▼ $46.70	$98.82M	0.73	2,677 shs	1,447 shs
MRMD MariMed	$0.08 -1.1%	$0.07	$0.06 ▼ $0.18	$31.75M	1.35	637,428 shs	412,370 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	0.00%	-10.26%	-44.04%	-60.50%	+445,999,900.00%
GRUSF Eagleford Energy	0.00%	-3.51%	-6.40%	-1.87%	-10.61%
KEQU Kewaunee Scientific	0.00%	-2.61%	-1.44%	-1.92%	-34.13%
MRMD MariMed	0.00%	-1.50%	+21.23%	+14.20%	-45.66%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNXU Conexeu Sciences	2.00	Hold	$20.00	348.43% Upside
GRUSF Eagleford Energy	0.00	N/A	N/A	N/A
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
MRMD MariMed	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest MRMD, CNXU, GRUSF, and KEQU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	CNXU Conexeu Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
6/30/2026	KEQU Kewaunee Scientific	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/22/2026	CNXU Conexeu Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$20.00

(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
GRUSF Eagleford Energy	$32.43M	3.36	N/A	N/A	$0.10 per share	4.40
KEQU Kewaunee Scientific	$282M	0.37	$6.23 per share	5.78	$26.80 per share	1.34
MRMD MariMed	$159.83M	0.20	$0.02 per share	3.40	$0.13 per share	0.61

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNXU Conexeu Sciences	-$3.92M	-$0.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GRUSF Eagleford Energy	$3.23M	-$0.02	N/A	N/A	N/A	-8.79%	-14.50%	-5.88%	11/18/2026 (Estimated)
KEQU Kewaunee Scientific	$9.62M	$2.76	13.05	N/A	N/A	2.97%	11.75%	4.78%	N/A
MRMD MariMed	-$14.48M	-$0.04	N/A	N/A	N/A	-9.13%	-10.71%	-2.58%	11/4/2026 (Estimated)

Latest MRMD, CNXU, GRUSF, and KEQU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q1 2027	KEQU Kewaunee Scientific	N/A	$0.58	N/A	$0.58	N/A	$66.32 million
8/12/2026	Q2 2026	MRMD MariMed	-$0.01	-$0.01	N/A	-$0.01	$39.80 million	$41.93 million
8/4/2026	Q2 2026	GRUSF Eagleford Energy	N/A	-$0.01	N/A	-$0.01	N/A	$11.27 million
6/23/2026	Q4 2026	KEQU Kewaunee Scientific	N/A	$1.14	N/A	$1.13	N/A	$71.40 million
6/15/2026	Q2 2026	CNXU Conexeu Sciences	N/A	-$0.11	N/A	-$0.11	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
GRUSF Eagleford Energy	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
MRMD MariMed	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNXU Conexeu Sciences	N/A	14.93	14.93
GRUSF Eagleford Energy	0.45	2.59	1.82
KEQU Kewaunee Scientific	0.53	2.18	1.55
MRMD MariMed	1.78	0.92	0.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNXU Conexeu Sciences	N/A
GRUSF Eagleford Energy	9.28%
KEQU Kewaunee Scientific	32.69%
MRMD MariMed	0.18%

Insider Ownership

Company	Insider Ownership
CNXU Conexeu Sciences	N/A
GRUSF Eagleford Energy	23.22%
KEQU Kewaunee Scientific	14.10%
MRMD MariMed	17.29%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNXU Conexeu Sciences	4	26.76 million	N/A	N/A
GRUSF Eagleford Energy	118,393	247.85 million	190.30 million	Not Optionable
KEQU Kewaunee Scientific	1,231	2.87 million	2.46 million	Not Optionable
MRMD MariMed	260	402.95 million	333.28 million	Not Optionable

MRMD, CNXU, GRUSF, and KEQU Headlines

Recent News About These Companies

MariMed delivers record revenue quarter as branded strategy gains momentum

August 20, 2026 | finance.yahoo.com

Marimed anticipates incremental federal reform clarity by year-end while targeting New York brand entry in H1 2027

August 13, 2026 | seekingalpha.com

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

August 13, 2026 | seekingalpha.com

MariMed Inc.: MariMed Reports Second Quarter 2026 Earnings

August 13, 2026 | finanznachrichten.de

MariMed Reports Second Quarter 2026 Earnings

August 12, 2026 | globenewswire.com

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers

August 6, 2026 | globenewswire.com

MariMed Announces Second Quarter 2026 Earnings Date

July 15, 2026 | globenewswire.com

MariMed’s Betty’s Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins

July 14, 2026 | finance.yahoo.com

MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins

July 14, 2026 | globenewswire.com

MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

July 7, 2026 | markets.businessinsider.com

MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

July 7, 2026 | globenewswire.com

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

June 25, 2026 | globenewswire.com

MariMed Presents Fourth Annual Bob Fireman Entrepreneur of the Year Award to Weldon Angelos

June 16, 2026 | globenewswire.com

Here's Why MariMed Inc. (MRMD) Could be Great Choice for a Bottom Fisher

June 15, 2026 | zacks.com

MariMed Inc (MRMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

May 14, 2026 | finance.yahoo.com

MariMed Inc.: MariMed Reports First Quarter 2026 Earnings

May 14, 2026 | finanznachrichten.de

MariMed Inc. (MRMD) Reports Q1 Loss, Beats Revenue Estimates

May 13, 2026 | zacks.com

MariMed Reports First Quarter 2026 Earnings

May 13, 2026 | globenewswire.com

Earnings To Watch: MariMed Inc (MRMD) Reports Q1 2026 Result

May 13, 2026 | finance.yahoo.com

MariMed (MRMD) price target increased by 106.25% to 0.17

April 28, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MRMD, CNXU, GRUSF, and KEQU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

$4.46 +0.21 (+4.94%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$4.46 0.00 (-0.11%)

As of 09/11/2026 07:41 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Eagleford Energy OTCMKTS:GRUSF

$0.44 +0.00 (+0.89%)

As of 09/11/2026 03:38 PM Eastern

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.

Kewaunee Scientific NASDAQ:KEQU

$36.02 +1.49 (+4.33%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$35.93 -0.09 (-0.26%)

As of 09/11/2026 04:10 PM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

MariMed OTCMKTS:MRMD

$0.08 0.00 (-1.13%)

As of 09/11/2026 03:57 PM Eastern

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MRMD, CNXU, GRUSF, and KEQU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MRMD, CNXU, GRUSF, and KEQU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MRMD, CNXU, GRUSF, and KEQU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MRMD, CNXU, GRUSF, and KEQU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Eagleford Energy OTCMKTS:GRUSF

Kewaunee Scientific NASDAQ:KEQU

MariMed OTCMKTS:MRMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MRMD, CNXU, GRUSF, and KEQU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MRMD, CNXU, GRUSF, and KEQU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MRMD, CNXU, GRUSF, and KEQU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MRMD, CNXU, GRUSF, and KEQU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Eagleford Energy OTCMKTS:GRUSF

Kewaunee Scientific NASDAQ:KEQU

MariMed OTCMKTS:MRMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools